Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond

Free Radical Biology and Medicine

Volumn 100, Issue , 2016, Pages 210-222

  Bingol, Baris ^a   Sheng, Morgan ^a  

^a GENENTECH INC   (United States)

Author keywords

Mitophagy; Parkin; Parkinson's Disease; PINK1; USP30

Indexed keywords

DEUBIQUITINASE; MITOCHONDRIAL KINASE PINK1; PARKIN; PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; USP15 PROTEIN; USP30 PROTEIN; USP35 PROTEIN; USP8 PROTEIN; MITOCHONDRIAL PROTEIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; THIOL ESTER HYDROLASE; UBIQUITIN PROTEIN LIGASE; USP30 PROTEIN, HUMAN;

ARTICLE; AUTOPHAGY; HUMAN; IN VIVO STUDY; MITOCHONDRION; MITOPHAGY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; METABOLISM; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMANS; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; PARKINSON DISEASE; PROTEIN KINASES; THIOLESTER HYDROLASES; UBIQUITIN-PROTEIN LIGASES;

EID: 84964603365     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.04.015     Document Type: Review

References (209)

1. [1] Harbauer, A.B., Zahedi, R.P., Sickmann, A., Pfanner, N., Meisinger, C., The protein import machinery of mitochondria-a regulatory hub in metabolism, stress, and disease. Cell Metab. 19:3 (2014), 357–372.
2. [2] Quiros, P.M., Langer, T., Lopez-Otin, C., New roles for mitochondrial proteases in health, ageing and disease. Nat. Rev. Mol. Cell Biol. 16:6 (2015), 345–359.
3. [3] Sena, L.A., Chandel, N.S., Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48:2 (2012), 158–167.
4. [4] Chan, D.C., Fusion and fission: interlinked processes critical for mitochondrial health. Annu. Rev. Genet. 46 (2012), 265–287.
5. [5] Aguilaniu, H., Gustafsson, L., Rigoulet, M., Nystrom, T., Asymmetric inheritance of oxidatively damaged proteins during cytokinesis. Science 299:5613 (2003), 1751–1753.
6. [6] Katajisto, P., Dohla, J., Chaffer, C.L., Pentinmikko, N., Marjanovic, N., Iqbal, S., Zoncu, R., Chen, W., Weinberg, R.A., Sabatini, D.M., Stem cells. Asymmetric apportioning of aged mitochondria between daughter cells is required for stemness. Science 348:6232 (2015), 340–343.
7. [7] Pickrell, A.M., Youle, R.J., The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85:2 (2015), 257–273.
8. [8] Nunnari, J., Suomalainen, A., Mitochondria: in sickness and in health. Cell 148:6 (2012), 1145–1159.
9. [9] Claramunt, R., Pedrola, L., Sevilla, T., Lopez de Munain, A., Berciano, J., Cuesta, A., Sanchez-Navarro, B., Millan, J.M., Saifi, G.M., Lupski, J.R., Vilchez, J.J., Espinos, C., Palau, F., Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect. J. Med. Genet. 42:4 (2005), 358–365.
10. [10] Baxter, R.V., Ben Othmane, K., Rochelle, J.M., Stajich, J.E., Hulette, C., Dew-Knight, S., Hentati, F., Ben Hamida, M., Bel, S., Stenger, J.E., Gilbert, J.R., Pericak-Vance, M.A., Vance, J.M., Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 30:1 (2002), 21–22.
11. [11] Delettre, C., Lenaers, G., Griffoin, J.M., Gigarel, N., Lorenzo, C., Belenguer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., Astarie-Dequeker, C., Lasquellec, L., Arnaud, B., Ducommun, B., Kaplan, J., Hamel, C.P., Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26:2 (2000), 207–210.
12. [12] Di Bella, D., Lazzaro, F., Brusco, A., Plumari, M., Battaglia, G., Pastore, A., Finardi, A., Cagnoli, C., Tempia, F., Frontali, M., Veneziano, L., Sacco, T., Boda, E., Brussino, A., Bonn, F., Castellotti, B., Baratta, S., Mariotti, C., Gellera, C., Fracasso, V., Magri, S., Langer, T., Plevani, P., Di Donato, S., Muzi-Falconi, M., Taroni, F., Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat. Genet. 42:4 (2010), 313–321.
13. [13] Edener, U., Wollner, J., Hehr, U., Kohl, Z., Schilling, S., Kreuz, F., Bauer, P., Bernard, V., Gillessen-Kaesbach, G., Zuhlke, C., Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. Eur. J. Hum. Genet. 18:8 (2010), 965–968.
14. [14] Zuchner, S., Mersiyanova, I.V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E.L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., Parman, Y., Evgrafov, O., Jonghe, P.D., Takahashi, Y., Tsuji, S., Pericak-Vance, M.A., Quattrone, A., Battaloglu, E., Polyakov, A.V., Timmerman, V., Schroder, J.M., Vance, J.M., Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:5 (2004), 449–451.
15. [15] Pfeiffer, R.F., Non-motor symptoms in Parkinson's disease. Parkinsonism Relat. Disord. 22:Suppl. 1 (2016), S119–S122.
16. [16] Matsuda, W., Furuta, T., Nakamura, K.C., Hioki, H., Fujiyama, F., Arai, R., Kaneko, T., Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum, The Journal of neuroscience: the official journal of the Society for. Neuroscience 29:2 (2009), 444–453.
17. [17] Pacelli, C., Giguere, N., Bourque, M.J., Levesque, M., Slack, R.S., Trudeau, L.E., Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr. Biol. 25:18 (2015), 2349–2360.
18. [18] Guzman, J.N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P.T., Surmeier, J.D., Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468:7324 (2010), 696–700.
19. [19] Haddad, D., Nakamura, K., Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease. FEBS Lett. 589:24 Pt Al (2015), 3702–3713.
20. [20] Diedrich, M., Kitada, T., Nebrich, G., Koppelstaetter, A., Shen, J., Zabel, C., Klose, J., Mao, L., Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease. Proteome Sci., 9(1), 2011, 59.
21. [21] Valente, E.M., Salvi, S., Ialongo, T., Marongiu, R., Elia, A.E., Caputo, V., Romito, L., Albanese, A., Dallapiccola, B., Bentivoglio, A.R., PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 56:3 (2004), 336–341.
22. [22] Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G., Albanese, A., Nussbaum, R., Gonzalez-Maldonado, R., Deller, T., Salvi, S., Cortelli, P., Gilks, W.P., Latchman, D.S., Harvey, R.J., Dallapiccola, B., Auburger, G., Wood, N.W., Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:5674 (2004), 1158–1160.
23. [23] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., Shimizu, N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:6676 (1998), 605–608.
24. [24] Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A., Guo, M., Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441:7097 (2006), 1162–1166.
25. [25] Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.M., Chung, J., Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441:7097 (2006), 1157–1161.
26. [26] Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.W., Yang, L., Beal, M.F., Vogel, H., Lu, B., Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. USA 103:28 (2006), 10793–10798.
27. [27] Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B., Pallanck, L.J., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. USA 100:7 (2003), 4078–4083.
28. [28] Geisler, S., Holmstrom, K.M., Skujat, D., Fiesel, F.C., Rothfuss, O.C., Kahle, P.J., Springer, W., PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12:2 (2010), 119–131.
29. [29] Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C.A., Sou, Y.S., Saiki, S., Kawajiri, S., Sato, F., Kimura, M., Komatsu, M., Hattori, N., Tanaka, K., PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189:2 (2010), 211–221.
30. [30] Narendra, D., Tanaka, A., Suen, D.F., Youle, R.J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183:5 (2008), 795–803.
31. [31] Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., Cookson, M.R., Youle, R.J., PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8(1), 2010, e1000298.
32. [32] Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R.L., Kim, J., May, J., Tocilescu, M.A., Liu, W., Ko, H.S., Magrane, J., Moore, D.J., Dawson, V.L., Grailhe, R., Dawson, T.M., Li, C., Tieu, K., Przedborski, S., PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA 107:1 (2010), 378–383.
33. [33] Sarraf, S.A., Raman, M., Guarani-Pereira, V., Sowa, M.E., Huttlin, E.L., Gygi, S.P., Harper, J.W., Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496:7445 (2013), 372–376.
34. [34] Bingol, B., Tea, J.S., Phu, L., Reichelt, M., Bakalarski, C.E., Song, Q., Foreman, O., Kirkpatrick, D.S., Sheng, M., The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510:7505 (2014), 370–375.
35. [35] Chan, N.C., Salazar, A.M., Pham, A.H., Sweredoski, M.J., Kolawa, N.J., Graham, R.L., Hess, S., Chan, D.C., Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20:9 (2011), 1726–1737.
36. [36] Yoshii, S.R., Kishi, C., Ishihara, N., Mizushima, N., Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 286:22 (2011), 19630–19640.
37. [37] Tanaka, A., Cleland, M.M., Xu, S., Narendra, D.P., Suen, D.F., Karbowski, M., Youle, R.J., Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191:7 (2010), 1367–1380.
38. [38] Wang, X., Winter, D., Ashrafi, G., Schlehe, J., Wong, Y.L., Selkoe, D., Rice, S., Steen, J., LaVoie, M.J., Schwarz, T.L., PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147:4 (2011), 893–906.
39. [39] Murphy, M.P., How mitochondria produce reactive oxygen species. Biochem. J. 417:1 (2009), 1–13.
40. [40] Yun, J., Finkel, T., Mitohormesis. Cell Metab. 19:5 (2014), 757–766.
41. [41] Pua, H.H., Guo, J., Komatsu, M., He, Y.W., Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J. Immunol. 182:7 (2009), 4046–4055.
42. [42] Tal, M.C., Sasai, M., Lee, H.K., Yordy, B., Shadel, G.S., Iwasaki, A., Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc. Natl. Acad. Sci. USA 106:8 (2009), 2770–2775.
43. [43] Kurihara, Y., Kanki, T., Aoki, Y., Hirota, Y., Saigusa, T., Uchiumi, T., Kang, D., Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J. Biol. Chem. 287:5 (2012), 3265–3272.
44. [44] Richard, V.R., Leonov, A., Beach, A., Burstein, M.T., Koupaki, O., Gomez-Perez, A., Levy, S., Pluska, L., Mattie, S., Rafesh, R., Iouk, T., Sheibani, S., Greenwood, M., Vali, H., Titorenko, V.I., Macromitophagy is a longevity assurance process that in chronologically aging yeast limited in calorie supply sustains functional mitochondria and maintains cellular lipid homeostasis. Aging 5:4 (2013), 234–269.
45. [45] Murata, H., Takamatsu, H., Liu, S., Kataoka, K., Huh, N.H., Sakaguchi, M., NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions. PLoS One, 10(11), 2015, e0142438.
46. [46] Frank, M., Duvezin-Caubet, S., Koob, S., Occhipinti, A., Jagasia, R., Petcherski, A., Ruonala, M.O., Priault, M., Salin, B., Reichert, A.S., Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner. Biochim. Biophys. Acta 1823:12 (2012), 2297–2310.
47. [47] Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., Elazar, Z., Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26:7 (2007), 1749–1760.
48. [48] Liu, L., Feng, D., Chen, G., Chen, M., Zheng, Q., Song, P., Ma, Q., Zhu, C., Wang, R., Qi, W., Huang, L., Xue, P., Li, B., Wang, X., Jin, H., Wang, J., Yang, F., Liu, P., Zhu, Y., Sui, S., Chen, Q., Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat. Cell Biol. 14:2 (2012), 177–185.
49. [49] Chen, M., Chen, Z., Wang, Y., Tan, Z., Zhu, C., Li, Y., Han, Z., Chen, L., Gao, R., Liu, L., Chen, Q., Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12:4 (2016), 689–702.
50. [50] Schulz, A.M., Haynes, C.M., UPR(mt)-mediated cytoprotection and organismal aging. Biochim. Biophys. Acta 1847:11 (2015), 1448–1456.
51. [51] Jovaisaite, V., Mouchiroud, L., Auwerx, J., The mitochondrial unfolded protein response, a conserved stress response pathway with implications in health and disease. J. Exp. Biol. 217:Pt 1 (2014), 137–143.
52. [52] Nargund, A.M., Fiorese, C.J., Pellegrino, M.W., Deng, P., Haynes, C.M., Mitochondrial and nuclear accumulation of the transcription factor ATFS-1 promotes OXPHOS recovery during the UPR(mt). Mol. Cell 58:1 (2015), 123–133.
53. [53] Dillin, A., Hsu, A.L., Arantes-Oliveira, N., Lehrer-Graiwer, J., Hsin, H., Fraser, A.G., Kamath, R.S., Ahringer, J., Kenyon, C., Rates of behavior and aging specified by mitochondrial function during development. Science 298:5602 (2002), 2398–2401.
54. [54] Durieux, J., Wolff, S., Dillin, A., The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144:1 (2011), 79–91.
55. [55] Owusu-Ansah, E., Song, W., Perrimon, N., Muscle mitohormesis promotes longevity via systemic repression of insulin signaling. Cell 155:3 (2013), 699–712.
56. [56] Houtkooper, R.H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., Williams, R.W., Auwerx, J., Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497:7450 (2013), 451–457.
57. [57] Mouchiroud, L., Houtkooper, R.H., Moullan, N., Katsyuba, E., Ryu, D., Canto, C., Mottis, A., Jo, Y.S., Viswanathan, M., Schoonjans, K., Guarente, L., Auwerx, J., The NAD(+)/Sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154:2 (2013), 430–441.
58. [58] Jin, S.M., Youle, R.J., The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 9:11 (2013), 1750–1757.
59. [59] Burbulla, L.F., Fitzgerald, J.C., Stegen, K., Westermeier, J., Thost, A.K., Kato, H., Mokranjac, D., Sauerwald, J., Martins, L.M., Woitalla, D., Rapaport, D., Riess, O., Proikas-Cezanne, T., Rasse, T.M., Kruger, R., Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1. Cell Death Dis., 5, 2014, e1180.
60. [60] Nargund, A.M., Pellegrino, M.W., Fiorese, C.J., Baker, B.M., Haynes, C.M., Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337:6094 (2012), 587–590.
61. [61] Runkel, E.D., Liu, S., Baumeister, R., Schulze, E., Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response. PLoS Genet., 9(3), 2013, e1003346.
62. [62] Pimenta de Castro, I., Costa, A.C., Lam, D., Tufi, R., Fedele, V., Moisoi, N., Dinsdale, D., Deas, E., Loh, S.H., Martins, L.M., Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ. 19:8 (2012), 1308–1316.
63. [63] Pellegrino, M.W., Haynes, C.M., Mitophagy and the mitochondrial unfolded protein response in neurodegeneration and bacterial infection. BMC Biol., 13, 2015, 22.
64. [64] Lazarou, M., Jin, S.M., Kane, L.A., Youle, R.J., Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev. Cell 22:2 (2012), 320–333.
65. [65] Deas, E., Plun-Favreau, H., Gandhi, S., Desmond, H., Kjaer, S., Loh, S.H., Renton, A.E., Harvey, R.J., Whitworth, A.J., Martins, L.M., Abramov, A.Y., Wood, N.W., PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum. Mol. Genet. 20:5 (2011), 867–879.
66. [66] Greene, A.W., Grenier, K., Aguileta, M.A., Muise, S., Farazifard, R., Haque, M.E., McBride, H.M., Park, D.S., Fon, E.A., Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep. 13:4 (2012), 378–385.
67. [67] Jin, S.M., Lazarou, M., Wang, C., Kane, L.A., Narendra, D.P., Youle, R.J., Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol. 191:5 (2010), 933–942.
68. [68] Meissner, C., Lorenz, H., Weihofen, A., Selkoe, D.J., Lemberg, M.K., The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J. Neurochem. 117:5 (2011), 856–867.
69. [69] Yamano, K., Youle, R.J., PINK1 is degraded through the N-end rule pathway. Autophagy 9:11 (2013), 1758–1769.
70. [70] Thomas, R.E., Andrews, L.A., Burman, J.L., Lin, W.Y., Pallanck, L.J., PINK1-Parkin pathway activity is regulated by degradation of PINK1 in the mitochondrial matrix. PLoS Genet., 10(5), 2014, e1004279.
71. [71] Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H.I., Campbell, D.G., Gourlay, R., Burchell, L., Walden, H., Macartney, T.J., Deak, M., Knebel, A., Alessi, D.R., Muqit, M.M., PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol., 2(5), 2012, 120080.
72. [72] Okatsu, K., Oka, T., Iguchi, M., Imamura, K., Kosako, H., Tani, N., Kimura, M., Go, E., Koyano, F., Funayama, M., Shiba-Fukushima, K., Sato, S., Shimizu, H., Fukunaga, Y., Taniguchi, H., Komatsu, M., Hattori, N., Mihara, K., Tanaka, K., Matsuda, N., PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria. Nat. Commun., 3, 2012, 1016.
73. [73] Aerts, L., Craessaerts, K., De Strooper, B., Morais, V.A., PINK1 kinase catalytic activity is regulated by phosphorylation on serines 228 and 402. J. Biol. Chem. 290:5 (2015), 2798–2811.
74. [74] Okatsu, K., Uno, M., Koyano, F., Go, E., Kimura, M., Oka, T., Tanaka, K., Matsuda, N., A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. J. Biol. Chem. 288:51 (2013), 36372–36384.
75. [75] Hasson, S.A., Kane, L.A., Yamano, K., Huang, C.H., Sliter, D.A., Buehler, E., Wang, C., Heman-Ackah, S.M., Hessa, T., Guha, R., Martin, S.E., Youle, R.J., High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy. Nature 504:7479 (2013), 291–295.
76. [76] Okatsu, K., Kimura, M., Oka, T., Tanaka, K., Matsuda, N., Unconventional PINK1 localization to the outer membrane of depolarized mitochondria drives Parkin recruitment. J. Cell Sci. 128:5 (2015), 964–978.
77. [77] Zhou, C., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C., Dauer, W., Schon, E.A., Przedborski, S., The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl. Acad. Sci. USA 105:33 (2008), 12022–12027.
78. [78] Wenzel, D.M., Lissounov, A., Brzovic, P.S., Klevit, R.E., UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT hybrids. Nature 474:7349 (2011), 105–108.
79. [79] Zheng, X., Hunter, T., Parkin mitochondrial translocation is achieved through a novel catalytic activity coupled mechanism. Cell Res. 23:7 (2013), 886–897.
80. [80] Lazarou, M., Narendra, D.P., Jin, S.M., Tekle, E., Banerjee, S., Youle, R.J., PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. J. Cell Biol. 200:2 (2013), 163–172.
81. [81] Smit, J.J., Sixma, T.K., RBR E3-ligases at work. EMBO Rep. 15:2 (2014), 142–154.
82. [82] Chaugule, V.K., Burchell, L., Barber, K.R., Sidhu, A., Leslie, S.J., Shaw, G.S., Walden, H., Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J. 30:14 (2011), 2853–2867.
83. [83] Riley, B.E., Lougheed, J.C., Callaway, K., Velasquez, M., Brecht, E., Nguyen, L., Shaler, T., Walker, D., Yang, Y., Regnstrom, K., Diep, L., Zhang, Z., Chiou, S., Bova, M., Artis, D.R., Yao, N., Baker, J., Yednock, T., Johnston, J.A., Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun., 4(2013), 1982.
84. [84] Trempe, J.F., Sauve, V., Grenier, K., Seirafi, M., Tang, M.Y., Menade, M., Al-Abdul-Wahid, S., Krett, J., Wong, K., Kozlov, G., Nagar, B., Fon, E.A., Gehring, K., Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340:6139 (2013), 1451–1455.
85. [85] Wauer, T., Komander, D., Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32:15 (2013), 2099–2112.
86. [86] Spratt, D.E., Martinez-Torres, R.J., Noh, Y.J., Mercier, P., Manczyk, N., Barber, K.R., Aguirre, J.D., Burchell, L., Purkiss, A., Walden, H., Shaw, G.S., A molecular explanation for the recessive nature of parkin-linked Parkinson's disease. Nat. Commun., 4(2013), 1983.
87. [87] Shiba-Fukushima, K., Imai, Y., Yoshida, S., Ishihama, Y., Kanao, T., Sato, S., Hattori, N., PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci. Rep., 2, 2012, 1002.
88. [88] Kane, L.A., Lazarou, M., Fogel, A.I., Li, Y., Yamano, K., Sarraf, S.A., Banerjee, S., Youle, R.J., PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205:2 (2014), 143–153.
89. [89] Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., Endo, T., Fon, E.A., Trempe, J.F., Saeki, Y., Tanaka, K., Matsuda, N., Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510:7503 (2014), 162–166.
90. [90] Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D.G., Ritorto, M.S., Hofmann, K., Alessi, D.R., Knebel, A., Trost, M., Muqit, M.M., Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochem. J. 460:1 (2014), 127–139.
91. [91] Ordureau, A., Sarraf, S.A., Duda, D.M., Heo, J.M., Jedrychowski, M.P., Sviderskiy, V.O., Olszewski, J.L., Koerber, J.T., Xie, T., Beausoleil, S.A., Wells, J.A., Gygi, S.P., Schulman, B.A., Harper, J.W., Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol. Cell 56:3 (2014), 360–375.
92. [92] Okatsu, K., Koyano, F., Kimura, M., Kosako, H., Saeki, Y., Tanaka, K., Matsuda, N., Phosphorylated ubiquitin chain is the genuine Parkin receptor. J. Cell Biol. 209:1 (2015), 111–128.
93. [93] Ordureau, A., Heo, J.M., Duda, D.M., Paulo, J.A., Olszewski, J.L., Yanishevski, D., Rinehart, J., Schulman, B.A., Harper, J.W., Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc. Natl. Acad. Sci. USA 112:21 (2015), 6637–6642.
94. [94] Wauer, T., Simicek, M., Schubert, A., Komander, D., Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature 524:7565 (2015), 370–374.
95. [95] Kazlauskaite, A., Martinez-Torres, R.J., Wilkie, S., Kumar, A., Peltier, J., Gonzalez, A., Johnson, C., Zhang, J., Hope, A.G., Peggie, M., Trost, M., van Aalten, D.M., Alessi, D.R., Prescott, A.R., Knebel, A., Walden, H., Muqit, M.M., Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep. 16:8 (2015), 939–954.
96. [96] Sauve, V., Lilov, A., Seirafi, M., Vranas, M., Rasool, S., Kozlov, G., Sprules, T., Wang, J., Trempe, J.F., Gehring, K., A Ubl/ubiquitin switch in the activation of Parkin. EMBO J. 34:20 (2015), 2492–2505.
97. [97] Kumar, A., Aguirre, J.D., Condos, T.E., Martinez-Torres, R.J., Chaugule, V.K., Toth, R., Sundaramoorthy, R., Mercier, P., Knebel, A., Spratt, D.E., Barber, K.R., Shaw, G.S., Walden, H., Disruption of the autoinhibited state primes the E3 ligase parkin for activation and catalysis. EMBO J. 34:20 (2015), 2506–2521.
98. [98] Lechtenberg, B.C., Rajput, A., Sanishvili, R., Dobaczewska, M.K., Ware, C.F., Mace, P.D., Riedl, S.J., Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation. Nature 529:7587 (2016), 546–550.
99. [99] Ordureau, A., Munch, C., Harper, J.W., Quantifying ubiquitin signaling. Mol. Cell 58:4 (2015), 660–676.
100. [100] Shiba-Fukushima, K., Inoshita, T., Hattori, N., Imai, Y., PINK1-mediated phosphorylation of Parkin boosts Parkin activity in Drosophila. PLoS Genet., 10(6), 2014, e1004391.
101. [101] Komander, D., Rape, M., The ubiquitin code. Annu. Rev. Biochem. 81 (2012), 203–229.
102. [102] Muller-Rischart, A.K., Pilsl, A., Beaudette, P., Patra, M., Hadian, K., Funke, M., Peis, R., Deinlein, A., Schweimer, C., Kuhn, P.H., Lichtenthaler, S.F., Motori, E., Hrelia, S., Wurst, W., Trumbach, D., Langer, T., Krappmann, D., Dittmar, G., Tatzelt, J., Winklhofer, K.F., The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol. Cell 49:5 (2013), 908–921.
103. [103] Cunningham, C.N., Baughman, J.M., Phu, L., Tea, J.S., Yu, C., Coons, M., Kirkpatrick, D.S., Bingol, B., Corn, J.E., USP30 and parkin homeostatically regulate atypical ubiquitin chains on mitochondria. Nat. Cell Biol. 17:2 (2015), 160–169.
104. [104] Wauer, T., Swatek, K.N., Wagstaff, J.L., Gladkova, C., Pruneda, J.N., Michel, M.A., Gersch, M., Johnson, C.M., Freund, S.M., Komander, D., Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. EMBO J. 34:3 (2015), 307–325.
105. [105] Swaney, D.L., Rodríguez-Mias, R.A., Villén, J., Phosphorylation of ubiquitin at Ser65 affects its polymerization, targets, and proteome-wide turnover. EMBO Rep. 16:9 (2015), 1131–1144.
106. [106] Shiba-Fukushima, K., Arano, T., Matsumoto, G., Inoshita, T., Yoshida, S., Ishihama, Y., Ryu, K.-Y.Y., Nukina, N., Hattori, N., Imai, Y., Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering. PLoS Genet., 10(12), 2014.
107. [107] Stolz, A., Ernst, A., Dikic, I., Cargo recognition and trafficking in selective autophagy. Nat. Cell Biol. 16:6 (2014), 495–501.
108. [108] Wong, Y.C., Holzbaur, E.L., Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. USA 111:42 (2014), E4439–E4448.
109. [109] Narendra, D., Kane, L.A., Hauser, D.N., Fearnley, I.M., Youle, R.J., p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6:8 (2010), 1090–1106.
110. [110] Richter, B., Sliter, D.A., Herhaus, L., Stolz, A., Wang, C., Beli, P., Zaffagnini, G., Wild, P., Martens, S., Wagner, S.A., Youle, R.J., Dikic, I., Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl. Acad. Sci. USA, 2016.
111. [111] Lazarou, M., Sliter, D.A., Kane, L.A., Sarraf, S.A., Wang, C., Burman, J.L., Sideris, D.P., Fogel, A.I., Youle, R.J., The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524:7565 (2015), 309–314.
112. [112] Heo, J.M., Ordureau, A., Paulo, J.A., Rinehart, J., Harper, J.W., The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60:1 (2015), 7–20.
113. [113] Wild, P., Farhan, H., McEwan, D.G., Wagner, S., Rogov, V.V., Brady, N.R., Richter, B., Korac, J., Waidmann, O., Choudhary, C., Dotsch, V., Bumann, D., Dikic, I., Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333:6039 (2011), 228–233.
114. [114] Matsumoto, G., Shimogori, T., Hattori, N., Nukina, N., TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum. Mol. Genet. 24:15 (2015), 4429–4442.
115. [115] Pilli, M., Arko-Mensah, J., Ponpuak, M., Roberts, E., Master, S., Mandell, M.A., Dupont, N., Ornatowski, W., Jiang, S., Bradfute, S.B., Bruun, J.A., Hansen, T.E., Johansen, T., Deretic, V., TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37:2 (2012), 223–234.
116. [116] Gleason, C.E., Ordureau, A., Gourlay, R., Arthur, J.S., Cohen, P., Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon beta. J. Biol. Chem. 286:41 (2011), 35663–35674.
117. [117] Burchell, V.S., Nelson, D.E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R.M., Pogson, J.H., Randle, S.J., Wray, S., Lewis, P.A., Houlden, H., Abramov, A.Y., Hardy, J., Wood, N.W., Whitworth, A.J., Laman, H., Plun-Favreau, H., The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat. Neurosci. 16:9 (2013), 1257–1265.
118. [118] Yun, J., Puri, R., Yang, H., Lizzio, M.A., Wu, C., Sheng, Z.H., Guo, M., MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin. Elife, 3, 2014, e01958.
119. [119] Ambivero, C.T., Cilenti, L., Main, S., Zervos, A.S., Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP. Cell Signal. 26:12 (2014), 2921–2929.
120. [120] Shi, R.Y., Zhu, S.H., Li, V., Gibson, S.B., Xu, X.S., Kong, J.M., BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci. Ther. 20:12 (2014), 1045–1055.
121. [121] Chakrabarti, L., Eng, J., Ivanov, N., Garden, G.A., La Spada, A.R., Autophagy activation and enhanced mitophagy characterize the Purkinje cells of pcd mice prior to neuronal death. Mol. Brain, 2, 2009, 24.
122. [122] Twig, G., Hyde, B., Shirihai, O.S., Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 1777:9 (2008), 1092–1097.
123. [123] Galluzzi, L., Pietrocola, F., Levine, B., Kroemer, G., Metabolic control of autophagy. Cell 159:6 (2014), 1263–1276.
124. [124] Hertz, N.T., Berthet, A., Sos, M.L., Thorn, K.S., Burlingame, A.L., Nakamura, K., Shokat, K.M., A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1. Cell 154:4 (2013), 737–747.
125. [125] Hasson, S.A., Fogel, A.I., Wang, C., MacArthur, R., Guha, R., Heman-Ackah, S., Martin, S., Youle, R.J., Inglese, J., Chemogenomic profiling of endogenous PARK2 expression using a genome-edited coincidence reporter. ACS Chem. Biol. 10:5 (2015), 1188–1197.
126. [126] Komander, D., Mechanism, specificity and structure of the deubiquitinases. Subcell. Biochem. 54 (2010), 69–87.
127. [127] Cornelissen, T., Haddad, D., Wauters, F., Van Humbeeck, C., Mandemakers, W., Koentjoro, B., Sue, C., Gevaert, K., De Strooper, B., Verstreken, P., Vandenberghe, W., The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum. Mol. Genet. 23:19 (2014), 5227–5242.
128. [128] Faronato, M., Patel, V., Darling, S., Dearden, L., Clague, M.J., Urbe, S., Coulson, J.M., The deubiquitylase USP15 stabilizes newly synthesized REST and rescues its expression at mitotic exit. Cell Cycle 12:12 (2013), 1964–1977.
129. [129] Iyengar, P.V., Jaynes, P., Rodon, L., Lama, D., Law, K.P., Lim, Y.P., Verma, C., Seoane, J., Eichhorn, P.J., USP15 regulates SMURF2 kinetics through C-lobe mediated deubiquitination. Sci. Rep., 5, 2015, 14733.
130. [130] Eichhorn, P.J., Rodon, L., Gonzalez-Junca, A., Dirac, A., Gili, M., Martinez-Saez, E., Aura, C., Barba, I., Peg, V., Prat, A., Cuartas, I., Jimenez, J., Garcia-Dorado, D., Sahuquillo, J., Bernards, R., Baselga, J., Seoane, J., USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma. Nat. Med. 18:3 (2012), 429–435.
131. [131] Herhaus, L., Al-Salihi, M.A., Dingwell, K.S., Cummins, T.D., Wasmus, L., Vogt, J., Ewan, R., Bruce, D., Macartney, T., Weidlich, S., Smith, J.C., Sapkota, G.P., USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. Open Biol., 4(5), 2014, 140065.
132. [132] Inui, M., Manfrin, A., Mamidi, A., Martello, G., Morsut, L., Soligo, S., Enzo, E., Moro, S., Polo, S., Dupont, S., Cordenonsi, M., Piccolo, S., USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13:11 (2011), 1368–1375.
133. [133] Zhang, H., Wang, D., Zhong, H., Luo, R., Shang, M., Liu, D., Chen, H., Fang, L., Xiao, S., Ubiquitin-specific protease 15 negatively regulates virus-induced type I interferon signaling via catalytically-dependent and -independent mechanisms. Sci. Rep., 5, 2015, 11220.
134. [134] Zou, Q., Jin, J., Hu, H., Li, H.S., Romano, S., Xiao, Y., Nakaya, M., Zhou, X., Cheng, X., Yang, P., Lozano, G., Zhu, C., Watowich, S.S., Ullrich, S.E., Sun, S.C., USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat. Immunol. 15:6 (2014), 562–570.
135. [135] Long, L., Thelen, J.P., Furgason, M., Haj-Yahya, M., Brik, A., Cheng, D., Peng, J., Yao, T., The U4/U6 recycling factor SART3 has histone chaperone activity and associates with USP15 to regulate H2B deubiquitination. J. Biol. Chem. 289:13 (2014), 8916–8930.
136. [136] Villeneuve, N.F., Tian, W., Wu, T., Sun, Z., Lau, A., Chapman, E., Fang, D., Zhang, D.D., USP15 negatively regulates Nrf2 through deubiquitination of Keap1. Mol. Cell 51:1 (2013), 68–79.
137. [137] Nakamura, N., Hirose, S., Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. Mol. Biol. Cell 19:5 (2008), 1903–1911.
138. [138] Wang, Y., Serricchio, M., Jauregui, M., Shanbhag, R., Stoltz, T., Di Paolo, C.T., Kim, P.K., McQuibban, G.A., Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 11:4 (2015), 595–606.
139. [139] Liang, J.R., Martinez, A., Lane, J.D., Mayor, U., Clague, M.J., Urbe, S., USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. EMBO Rep. 16:5 (2015), 618–627.
140. [140] MacDonald, E., Urbe, S., Clague, M.J., USP8 controls the trafficking and sorting of lysosomal enzymes. Traffic 15:8 (2014), 879–888.
141. [141] Durcan, T.M., Tang, M.Y., Perusse, J.R., Dashti, E.A., Aguileta, M.A., McLelland, G.L., Gros, P., Shaler, T.A., Faubert, D., Coulombe, B., Fon, E.A., USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J. 33:21 (2014), 2473–2491.
142. [142] Row, P.E., Prior, I.A., McCullough, J., Clague, M.J., Urbe, S., The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation. J. Biol. Chem. 281:18 (2006), 12618–12624.
143. [143] Bondalapati, S., Mansour, W., Nakasone, M.A., Maity, S.K., Glickman, M.H., Brik, A., Chemical synthesis of phosphorylated ubiquitin and diubiquitin exposes positional sensitivities of e1-e2 enzymes and deubiquitinases. Chemistry 21:20 (2015), 7360–7364.
144. [144] Fiesel, F.C., Ando, M., Hudec, R., Hill, A.R., Castanedes-Casey, M., Caulfield, T.R., Moussaud-Lamodiere, E.L., Stankowski, J.N., Bauer, P.O., Lorenzo-Betancor, O., Ferrer, I., Arbelo, J.M., Siuda, J., Chen, L., Dawson, V.L., Dawson, T.M., Wszolek, Z.K., Ross, O.A., Dickson, D.W., Springer, W., (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. EMBO Rep. 16:9 (2015), 1114–1130.
145. [145] Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J.N., Rovio, A.T., Bruder, C.E., Bohlooly, Y.M., Gidlof, S., Oldfors, A., Wibom, R., Tornell, J., Jacobs, H.T., Larsson, N.G., Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:6990 (2004), 417–423.
146. [146] Kujoth, G.C., Hiona, A., Pugh, T.D., Someya, S., Panzer, K., Wohlgemuth, S.E., Hofer, T., Seo, A.Y., Sullivan, R., Jobling, W.A., Morrow, J.D., Van Remmen, H., Sedivy, J.M., Yamasoba, T., Tanokura, M., Weindruch, R., Leeuwenburgh, C., Prolla, T.A., Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:5733 (2005), 481–484.
147. [147] Pickrell, A.M., Huang, C.H., Kennedy, S.R., Ordureau, A., Sideris, D.P., Hoekstra, J.G., Harper, J.W., Youle, R.J., Endogenous parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87:2 (2015), 371–381.
148. [148] Sterky, F.H., Lee, S., Wibom, R., Olson, L., Larsson, N.G., Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl. Acad. Sci. USA 108:31 (2011), 12937–12942.
149. [149] Chen, L., Xie, Z., Turkson, S., Zhuang, X., A53T human alpha-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J. Neurosci. 35:3 (2015), 890–905.
150. [150] Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J., Gajendiran, M., Roth, B.L., Chesselet, M.F., Maidment, N.T., Levine, M.S., Shen, J., Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278:44 (2003), 43628–43635.
151. [151] Kitada, T., Pisani, A., Porter, D.R., Yamaguchi, H., Tscherter, A., Martella, G., Bonsi, P., Zhang, C., Pothos, E.N., Shen, J., Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice. Proc. Natl. Acad. Sci. USA 104:27 (2007), 11441–11446.
152. [152] Kitada, T., Tong, Y., Gautier, C.A., Shen, J., Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice. J. Neurochem. 111:3 (2009), 696–702.
153. [153] Itier, J.M., Ibanez, P., Mena, M.A., Abbas, N., Cohen-Salmon, C., Bohme, G.A., Laville, M., Pratt, J., Corti, O., Pradier, L., Ret, G., Joubert, C., Periquet, M., Araujo, F., Negroni, J., Casarejos, M.J., Canals, S., Solano, R., Serrano, A., Gallego, E., Sanchez, M., Denefle, P., Benavides, J., Tremp, G., Rooney, T.A., Brice, A., Garcia de Yebenes, J., Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum. Mol. Genet. 12:18 (2003), 2277–2291.
154. [154] Von Coelln, R., Thomas, B., Savitt, J.M., Lim, K.L., Sasaki, M., Hess, E.J., Dawson, V.L., Dawson, T.M., Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc. Natl. Acad. Sci. USA 101:29 (2004), 10744–10749.
155. [155] Perez, F.A., Palmiter, R.D., Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl. Acad. Sci. USA 102:6 (2005), 2174–2179.
156. [156] Akundi, R.S., Huang, Z., Eason, J., Pandya, J.D., Zhi, L., Cass, W.A., Sullivan, P.G., Bueler, H., Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS One, 6(1), 2011, e16038.
157. [157] Dave, K.D., De Silva, S., Sheth, N.P., Ramboz, S., Beck, M.J., Quang, C., Switzer, R.C. 3rd, Ahmad, S.O., Sunkin, S.M., Walker, D., Cui, X., Fisher, D.A., McCoy, A.M., Gamber, K., Ding, X., Goldberg, M.S., Benkovic, S.A., Haupt, M., Baptista, M.A., Fiske, B.K., Sherer, T.B., Frasier, M.A., Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease. Neurobiol. Dis. 70 (2014), 190–203.
158. [158] Vincow, E.S., Merrihew, G., Thomas, R.E., Shulman, N.J., Beyer, R.P., MacCoss, M.J., Pallanck, L.J., The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc. Natl. Acad. Sci. USA 110:16 (2013), 6400–6405.
159. [159] Kim, T.Y., Wang, D., Kim, A.K., Lau, E., Lin, A.J., Liem, D.A., Zhang, J., Zong, N.C., Lam, M.P., Ping, P., Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol. Cell. Proteom. 11:12 (2012), 1586–1594.
160. [160] Sugiura, A., McLelland, G.L., Fon, E.A., McBride, H.M., A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 33:19 (2014), 2142–2156.
161. [161] Soubannier, V., Rippstein, P., Kaufman, B.A., Shoubridge, E.A., McBride, H.M., Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS One, 7(12), 2012, e52830.
162. [162] Neuspiel, M., Schauss, A.C., Braschi, E., Zunino, R., Rippstein, P., Rachubinski, R.A., Andrade-Navarro, M.A., McBride, H.M., Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18:2 (2008), 102–108.
163. [163] Soubannier, V., McLelland, G.L., Zunino, R., Braschi, E., Rippstein, P., Fon, E.A., McBride, H.M., A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22:2 (2012), 135–141.
164. [164] McLelland, G.L., Soubannier, V., Chen, C.X., McBride, H.M., Fon, E.A., Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J. 33:4 (2014), 282–295.
165. [165] Sun, N., Yun, J., Liu, J., Malide, D., Liu, C., Rovira, K.M. II, Holmstrom, M.M., Fergusson, Y.H., Yoo, C.A., Finkel, Combs, T., Measuring In Vivo Mitophagy. Mol. Cell 60:4 (2015), 685–696.
166. [166] Chan, X.C., Black, C.M., Lin, A.J., Ping, P., Lau, E., Mitochondrial protein turnover: methods to measure turnover rates on a large scale. J. Mol. Cell. Cardiol. 78 (2015), 54–61.
167. [167] Katayama, H., Kogure, T., Mizushima, N., Yoshimori, T., Miyawaki, A., A sensitive and quantitative technique for detecting autophagic events based on lysosomal delivery. Chem. Biol. 18 (2011), 1042–1094 7e9d2f47-4d52-0c56-1ceb-635c3ffa0b21.
168. [168] Edgar, D., Shabalina, I., Camara, Y., Wredenberg, A., Calvaruso, M.A., Nijtmans, L., Nedergaard, J., Cannon, B., Larsson, N.G., Trifunovic, A., Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice. Cell Metab. 10:2 (2009), 131–138.
169. [169] Veeriah, S., Taylor, B.S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., Janakiraman, M., Schultz, N., Hanrahan, A.J., Pao, W., Ladanyi, M., Sander, C., Heguy, A., Holland, E.C., Paty, P.B., Mischel, P.S., Liau, L., Cloughesy, T.F., Mellinghoff, I.K., Solit, D.B., Chan, T.A., Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42:1 (2010), 77–82.
170. [170] Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., Komure, O., Matsuura, S., Kobatake, K., Morimoto, N., Abe, K., Suzuki, N., Aoki, M., Kawata, A., Hirai, T., Kato, T., Ogasawara, K., Hirano, A., Takumi, T., Kusaka, H., Hagiwara, K., Kaji, R., Kawakami, H., Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465:7295 (2010), 223–226.
171. [171] Rubino, E., Rainero, I., Chio, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S., Bruni, A.C., George-Hyslop, P.H. St, Scarpini, E., Gallone, S., Pinessi, L., Group, T.S., SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79:15 (2012), 1556–1562.
172. [172] Shen, W.C., Li, H.Y., Chen, G.C., Chern, Y., Tu, P.H., Mutations in the ubiquitin-binding domain of OPTN/optineurin interfere with autophagy-mediated degradation of misfolded proteins by a dominant-negative mechanism. Autophagy 11:4 (2015), 685–700.
173. [173] Pottier, C., Bieniek, K.F., Finch, N., van de Vorst, M., Baker, M., Perkersen, R., Brown, P., Ravenscroft, T., van Blitterswijk, M., Nicholson, A.M., DeTure, M., Knopman, D.S., Josephs, K.A., Parisi, J.E., Petersen, R.C., Boylan, K.B., Boeve, B.F., Graff-Radford, N.R., Veltman, J.A., Gilissen, C., Murray, M.E., Dickson, D.W., Rademakers, R., Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 130:1 (2015), 77–92.
174. [174] Cirulli, E.T., Lasseigne, B.N., Petrovski, S., Sapp, P.C., Dion, P.A., Leblond, C.S., Couthouis, J., Lu, Y.F., Wang, Q., Krueger, B.J., Ren, Z., Keebler, J., Han, Y., Levy, S.E., Boone, B.E., Wimbish, J.R., Waite, L.L., Jones, A.L., Carulli, J.P., Day-Williams, A.G., Staropoli, J.F., Xin, W.W., Chesi, A., Raphael, A.R., McKenna-Yasek, D., Cady, J., Vianney de Jong, J.M., Kenna, K.P., Smith, B.N., Topp, S., Miller, J., Gkazi, A., Consortium, F.S., Al-Chalabi, A., van den Berg, L.H., Veldink, J., Silani, V., Ticozzi, N., Shaw, C.E., Baloh, R.H., Appel, S., Simpson, E., Lagier-Tourenne, C., Pulst, S.M., Gibson, S., Trojanowski, J.Q., Elman, L., McCluskey, L., Grossman, M., Shneider, N.A., Chung, W.K., Ravits, J.M., Glass, J.D., Sims, K.B., Van Deerlin, V.M., Maniatis, T., Hayes, S.D., Ordureau, A., Swarup, S., Landers, J., Baas, F., Allen, A.S., Bedlack, R.S., Harper, J.W., Gitler, A.D., Rouleau, G.A., Brown, R., Harms, M.B., Cooper, G.M., Harris, T., Myers, R.M., Goldstein, D.B., Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347:6229 (2015), 1436–1441.
175. [175] Gong, G., Song, M., Csordas, G., Kelly, D.P., Matkovich, S.J., Dorn, G.W., Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science, 350(6265), 2015.
176. [176] Huang, C., Andres, A.M., Ratliff, E.P., Hernandez, G., Lee, P., Gottlieb, R.A., Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One, 6(6), 2011, e20975.
177. [177] Andres, A.M., Hernandez, G., Lee, P., Huang, C., Ratliff, E.P., Sin, J., Thornton, C.A., Damasco, M.V., Gottlieb, R.A., Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. 21:14 (2014), 1960–1973.
178. [178] Piquereau, J., Godin, R., Deschenes, S., Bessi, V.L., Mofarrahi, M., Hussain, S.N., Burelle, Y., Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction. Autophagy 9:11 (2013), 1837–1851.
179. [179] Lazarou, M., Keeping the immune system in check: a role for mitophagy. Immunol. Cell Biol. 93:1 (2015), 3–10.
180. [180] Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., Oyabu, J., Murakawa, T., Nakayama, H., Nishida, K., Akira, S., Yamamoto, A., Komuro, I., Otsu, K., Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485:7397 (2012), 251–255.
181. [181] Shimada, K., Crother, T.R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V.K., Wolf, A.J., Vergnes, L., Ojcius, D.M., Rentsendorj, A., Vargas, M., Guerrero, C., Wang, Y., Fitzgerald, K.A., Underhill, D.M., Town, T., Arditi, M., Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36:3 (2012), 401–414.
182. [182] Koshiba, T., Yasukawa, K., Yanagi, Y., Kawabata, S., Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci. Signal., 4(158), 2011 ra7.
183. [183] Duan, X., Tong, J., Xu, Q., Wu, Y., Cai, F., Li, T., Song, W., Upregulation of human PINK1 gene expression by NFkappaB signalling. Mol. Brain, 7, 2014, 57.
184. [184] Zhong, Z., Umemura, A., Sanchez-Lopez, E., Liang, S., Shalapour, S., Wong, J., He, F., Boassa, D., Perkins, G., Ali, S.R., McGeough, M.D., Ellisman, M.H., Seki, E., Gustafsson, A.B., Hoffman, H.M., Diaz-Meco, M.T., Moscat, J., Karin, M., NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164:5 (2016), 896–910.
185. [185] Manzanillo, P.S., Ayres, J.S., Watson, R.O., Collins, A.C., Souza, G., Rae, C.S., Schneider, D.S., Nakamura, K., Shiloh, M.U., Cox, J.S., The ubiquitin ligase parkin mediates resistance to intracellular pathogens. Nature 501:7468 (2013), 512–516.
186. [186] Mira, M.T., Alcais, A., Nguyen, V.T., Moraes, M.O., Di Flumeri, C., Vu, H.T., Mai, C.P., Nguyen, T.H., Nguyen, N.B., Pham, X.K., Sarno, E.N., Alter, A., Montpetit, A., Moraes, M.E., Moraes, J.R., Dore, C., Gallant, C.J., Lepage, P., Verner, A., Van De Vosse, E., Hudson, T.J., Abel, L., Schurr, E., Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427:6975 (2004), 636–640.
187. [187] Chopra, R., Kalaiarasan, P., Ali, S., Srivastava, A.K., Aggarwal, S., Garg, V.K., Bhattacharya, S.N., Bamezai, R.N., PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population. BMJ Open, 4(2), 2014, e004239.
188. [188] Kim, S.J., Khan, M., Quan, J., Till, A., Subramani, S., Siddiqui, A., Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog., 9(12), 2013, e1003722.
189. [189] Kim, S.J., Syed, G.H., Siddiqui, A., Hepatitis C virus induces the mitochondrial translocation of Parkin and subsequent mitophagy. PLoS Pathog., 9(3), 2013, e1003285.
190. [190] Williams, J.A., Ding, W.X., Targeting Pink1-Parkin-mediated mitophagy for treating liver injury. Pharmacol. Res. 102 (2015), 264–269.
191. [191] Bueno, M., Lai, Y.C., Romero, Y., Brands, J., St Croix, C.M., Kamga, C., Corey, C., Herazo-Maya, J.D., Sembrat, J., Lee, J.S., Duncan, S.R., Rojas, M., Shiva, S., Chu, C.T., Mora, A.L., PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J. Clin. Invest. 125:2 (2015), 521–538.
192. [192] Schweers, R.L., Zhang, J., Randall, M.S., Loyd, M.R., Li, W., Dorsey, F.C., Kundu, M., Opferman, J.T., Cleveland, J.L., Miller, J.L., Ney, P.A., NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc. Natl. Acad. Sci. USA 104:49 (2007), 19500–19505.
193. [193] Clague, M.J., Heride, C., Urbe, S., The demographics of the ubiquitin system. Trends Cell Biol. 25:7 (2015), 417–426.
194. [194] Ohtake, F., Saeki, Y., Sakamoto, K., Ohtake, K., Nishikawa, H., Tsuchiya, H., Ohta, T., Tanaka, K., Kanno, J., Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep. 16:2 (2015), 192–201.
195. [195] Ivankovic, D., Chau, K.Y., Schapira, A.H., Gegg, M.E., Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy. J. Neurochem. 136:2 (2016), 388–402.
196. [196] Nezich, C.L., Wang, C., Fogel, A.I., Youle, R.J., MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J. Cell Biol. 210:3 (2015), 435–450.
197. [197] Lai, Y.C., Kondapalli, C., Lehneck, R., Procter, J.B., Dill, B.D., Woodroof, H.I., Gourlay, R., Peggie, M., Macartney, T.J., Corti, O., Corvol, J.C., Campbell, D.G., Itzen, A., Trost, M., Muqit, M.M., Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 34:22 (2015), 2840–2861.
198. [198] Yamano, K., Fogel, A.I., Wang, C., van der Bliek, A.M., Youle, R.J., Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. Elife, 3, 2014, e01612.
199. [199] Laforge, M., Rodrigues, V., Silvestre, R., Gautier, C., Weil, R., Corti, O., Estaquier, J., NF-kappaB pathway controls mitochondrial dynamics. Cell Death Differ. 23:1 (2016), 89–98.
200. [200] Gehrke, S., Wu, Z., Klinkenberg, M., Sun, Y., Auburger, G., Guo, S., Lu, B., PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane. Cell Metab. 21:1 (2015), 95–108.
201. [201] Liu, S., Sawada, T., Lee, S., Yu, W., Silverio, G., Alapatt, P., Millan, I., Shen, A., Saxton, W., Kanao, T., Takahashi, R., Hattori, N., Imai, Y., Lu, B., Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet., 8(3), 2012, e1002537.
202. [202] Pogson, J.H., Ivatt, R.M., Sanchez-Martinez, A., Tufi, R., Wilson, E., Mortiboys, H., Whitworth, A.J., The complex I subunit NDUFA10 selectively rescues Drosophila pink1 mutants through a mechanism independent of mitophagy. PLoS Genet., 10(11), 2014, e1004815.
203. [203] Morais, V.A., Haddad, D., Craessaerts, K., De Bock, P.J., Swerts, J., Vilain, S., Aerts, L., Overbergh, L., Grunewald, A., Seibler, P., Klein, C., Gevaert, K., Verstreken, P., De Strooper, B., PINK1 loss-of-function mutations affect mitochondrial complex I activity via NdufA10 ubiquinone uncoupling. Science 344:6180 (2014), 203–207.
204. [204] Stevens, D.A., Lee, Y., Kang, H.C., Lee, B.D., Lee, Y.I., Bower, A., Jiang, H., Kang, S.U., Andrabi, S.A., Dawson, V.L., Shin, J.H., Dawson, T.M., Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc. Natl. Acad. Sci. USA 112:37 (2015), 11696–11701.
205. [205] Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., Troconso, J.C., Dawson, V.L., Dawson, T.M., PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144:5 (2011), 689–702.
206. [206] Nalls, M.A., Pankratz, N., Lill, C.M., Do, C.B., Hernandez, D.G., Saad, M., DeStefano, A.L., Kara, E., Bras, J., Sharma, M., Schulte, C., Keller, M.F., Arepalli, S., Letson, C., Edsall, C., Stefansson, H., Liu, X., Pliner, H., Lee, J.H., Cheng, R., International Parkinson's Disease Genomics, C., Parkinson's Study Group Parkinson's Research: The Organized, G.I., Me, GenePd, NeuroGenetics Research, C., Hussman Institute of Human, G., Ashkenazi Jewish Dataset, I., Cohorts for, H., Aging Research in Genetic, E., North American Brain Expression, C., United Kingdom Brain Expression, C., Greek Parkinson's Disease, C., Alzheimer Genetic Analysis, G., Ikram, M.A., Ioannidis, J.P., Hadjigeorgiou, G.M., Bis, J.C., Martinez, M., Perlmutter, J.S., Goate, A., Marder, K., Fiske, B., Sutherland, M., Xiromerisiou, G., Myers, R.H., Clark, L.N., Stefansson, K., Hardy, J.A., Heutink, P., Chen, H., Wood, N.W., Houlden, H., Payami, H., Brice, A., Scott, W.K., Gasser, T., Bertram, L., Eriksson, N., Foroud, T., Singleton, A.B., Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat. Genet. 46:9 (2014), 989–993.
207. [207] Osellame, L.D., Rahim, A.A., Hargreaves, I.P., Gegg, M.E., Richard-Londt, A., Brandner, S., Waddington, S.N., Schapira, A.H., Duchen, M.R., Mitochondria and quality control defects in a mouse model of Gaucher disease – links to Parkinson's disease. Cell Metab. 17:6 (2013), 941–953.
208. [208] Ivatt, R.M., Sanchez-Martinez, A., Godena, V.K., Brown, S., Ziviani, E., Whitworth, A.J., Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy. Proc. Natl. Acad. Sci. USA 111:23 (2014), 8494–8499.
209. [209] Weiner, W.J., There is no Parkinson disease. Arch. Neurol. 65:6 (2008), 705–708.